搜尋結果
AstraZeneca's COVID prevention drug meets primary goals in late-stage study
Reuters· 10 小時前AstraZeneca's investigational COVID-19 prevention therapy met its primary goals in a ...
Shares of this gene editing company are due to surge more than 45%, Citi says
CNBC· 3 小時前After a period of steady underperformance, investors should pick up shares of biotech Prime ...
FDA To Hold Advisory Committee Meeting On MDMA Therapy For PTSD, Welcomes Public Comment
Forbes· 5 日前The U.S. Food and Drug Administration (FDA) recently announced an upcoming committee meeting ...
Evercore ISI says three years of biotech underperformance may be ending, gives its 5 favorite stocks
CNBC· 2 日前The outlook on biotechnology is finally turning positive, according to Evercore ISI, which ...